The retail giant is teaming up with Clover Health to market Medicare Advantage plans in eight counties in Georgia.
Walmart is poised to branch out even further into the healthcare sector with today’s announcement that it is partnering with Clover Health to offer Medicare Advantage plans in eight counties in northeastern Georgia next year.
Today’s Medicare Advantage announcement comes two week after a September 17 blog post by Lori Flees, senior vice president and chief operating officer of Walmart Health and Fitness, about the retailer’s expansion plans for its Walmart Health centers. Flees wrote that the giant retailer plans to open seven more of the health centers in Georgia this year, which would bring the total in the state to 12, and also two in the Chicago.
Lori Flees
The new Medicare Advantage plans will be called “Live Healthy: Clover Powered, Walmart Enhanced (PPO)”, and “Live Healthy LI: Clover Powered, Walmart Enhanced (PPO)." A Clover spokesperson said that The LiveHealthy LI plan is for people who might qualify for a low-income subsidy that will lower their prescription costs and add benefits. Today’s press release, which came from Clover, says the company’s proprietary software, called Clover Assistant, will support providers at the Walmart Health centers with data, clinical guidelines and machine learning “to surface the most urgent patient needs.”
"The Walmart brand is synonymous with the best value and low prices, and that's exactly what we're doing at Clover," said Andrew Toy, president and CTO of Clover Health, said in the press release.
Andrew Toy
The news of the Walmart-Clover Medicare Advantage came amid a flurry of reports about companies expanding the number off counties where they are selling Medicare Advantage plans.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen